Regeneron (REGN) stock is in focus as the FDA approves a label expansion for Evkeeza its cholesterol therapy marketed with Ultragenyx (RARE). Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback